Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 6, 2003, Pages 623-636

  Waldmüller, Stephan ^a   Sakthivel, Sadayappan ^a,e   Saadi, Abdul Vahab ^b   Selignow, Carmen ^a   Rakesh, Pareppally Gopal ^c   Golubenko, Maria ^a   Joseph, Pulavelli Kurian ^c   Padmakumar, Ramachandran ^c   Richard, Pascale ^d   Schwartz, Ketty ^d   Tharakan, Jagan Mohan ^c   Rajamanickam, Chellam ^b   Vosberg, Hans Peter ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b MADURAI KAMARAJ UNIVERSITY   (India)

^c SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Deletion mutations; Familial hypertrophic cardiomyopathy; Indian families; MYBPC3; MYH7

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CHILD; CHROMOSOME 11; CHROMOSOME 14; CLINICAL ARTICLE; CODON; COMPARATIVE STUDY; CONTROLLED STUDY; DELETION MUTANT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EXON; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE IDENTIFICATION; GENE LOSS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC EPISTASIS; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HETEROZYGOSITY LOSS; HUMAN; INTRON; MALE; MEDICAL ASSESSMENT; MUTATIONAL ANALYSIS; MUTATOR GENE; PRIORITY JOURNAL; RNA SPLICING; SUDDEN DEATH;

EID: 12444285444     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00050-6     Document Type: Article

References (42)

1. Maron B.J., Bonow R.O., Cannon R.O., Leon M.B., Epstein S.E. Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathophysiology, and therapy (first of two parts). N Engl J M. 316:1987;780-789.
2. Watkins H., Seidman J.G., Seidman C.E. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet. 4:1995;1721-1727.
3. Vosberg H.P., McKenna W.J. Cardiomyopathies. Rimoin D.L., Connor J.M., Pyeritz R.E., Korf B.R. Emery and Rimoin's Principles and Practice of Medical Genetics. 4th:2002;1342-1346 Churchill Livingstone, London.
4. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., Vosberg H.P., McKenna W., Seidman C.E., et al. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell. 62:1990;999-1006.
5. Watkins H., Conner D., Thierfelder L., Jarcho J.A., Macrae C., McKenna W.J., et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;434-437.
6. Bonne G., Carrier L., Bercovici J., Cruaud C., Richard P., Hainque B., et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 11:1995;438-440.
7. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., et al. α-Tropomyosin and cardiac Troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 77:1994;701-712.
8. Kimura A., Harada H., Park J- E., Nishi H., Satoh M., Takahashi M., et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 16:1997;379-382.
9. Poetter K., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 13:1996;63-69.
10. Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T.A., et al. α-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest. 103:1999;39-43.
11. Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun. 262:1999;411-417.
12. Hoffmann B., Schmidt-Traub H., Perrot A., Osterziel K.J., Gessner R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum Mutat. 17:2001;524.
13. Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation. 105:2002;446-451.
14. 2 subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Gen. 10:2001;1215-1220.
15. Arad A., Benson W.D., Perez-Atayde A.R., McKenna W.J., Sparks E.A., Kanter R.J., et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 109:2002;357-362.
16. Bonne G., Carrier L., Richard P., Hainque B., Schwartz K. Familial hypertrophic cardiomyopathy. From mutations to functional defects. Circ Res. 83:1998;580-593.
17. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W.J., Seidman C.E., et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J M. 326:1992;1108-1114.
18. Anan R., Greve G., Thierfelder L., Watkins H., McKenna W.J., Solomon S., et al. Prognostic implications of novel β cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest. 93:1994;280-285.
19. Watkins H., McKenna W.J., Thierfelder L., Suk H.J., Anan R., O'Donoghue A., et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J M. 332:1995;1058-1064.
20. Moolman J.A., Reith S., Uhl K., Bailey S., Gautel M., Jeschke B., et al. A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance. Circulation. 101:2000;1396-1402.
21. Arg-Leu) in the cardiac β-myosin heavy chain gene causing hypertrophic cardiomyopathy in an Indian family. Hum Mutat. 15:2000;298-299.
22. Ortlepp J.R., Vosberg H.P., Reith S., Ohme F., Mahon N.G., Schröder D., et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene. Heart. 87:2002;270-275.
23. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 55:1977;613-618.
24. Jaenicke T., Diederich K.W., Haas W., Schleich J., Lichter P., Pfordt M., et al. The complete sequence of the human β-myosin heavy chain gene and a comparative analysis of its product. Genomics. 8:1990;194-206.
25. Carrier L., Bonne G., Bahrend E., Yu B., Richard P., Niel F., et al. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy. Circ Res. 80:1997;427-434.
26. Orita M., Iwahana H., Kanazawa H., Hayashi K., Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA. 86:1989;2766-2770.
27. Dib C., Fauré S., Fizames C., Samson D., Drouot N., Vignal A., et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 380:1996;152-154. (Supplementary Table 1, p. A77).
28. Verpy E., Biasotto M., Meo T., Tosi M. Efficient detection of point mutations on color-coded strands of target DNA. Proc Natl Acad Sci USA. 91:1994;1873-1877.
29. Ronaghi M., Uhlen M., Nyren P. A sequencing method based on real-time pyrophosphate. Science. 281:1998;363-365.
30. Buja L.M., Muntz K.H., Rosenbaum T., Haghani Z., Buja D.K., Sen A., et al. Characterization of potentially reversible increase in β-adrenargic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism. Circ Res. 57:1985;640-645.
31. Jaaskelainen P., Soranta M., Miettinen R., Saarinen L., Pihlajamaki J., Silvennoinen K., et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Card. 32:1998;1709-1716.
32. Moolman-Smook J.C., De Lange W.J., Bruwer E.C.D., Brink P.A., Corfield V.A. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet. 65:1999;1308-1320.
33. McLachlan A.D., Karn J. Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle. Nature. 299:1982;226-231.
34. Offer G., Knight P.J. The structure of the head-tail junction of the myosin molecular. J Mol Biol. 256:1996;407-416.
35. Rottbauer W., Gautel M., Zehelein J., Labeit S., Franz W.M., Fischer C., et al. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization of cardiac transcript and protein. J Clin Invest. 100:1997;475-482.
36. Maquat L.E., carmichael G.G. Quality control of mRNA function. Cell. 104:2001;173-176.
37. Varshavsky A., Turner G., Du F., Xie Y. The ubiquitin system and the N-end rule pathway. Biol Chem. 381:2000;779-789.
38. Seidman J.G., Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 104:2001;557-567.
39. Flavigny J., Souchet M., Sebillon P., Berrebi-Bertrand I., Hainque B., Mallet A., et al. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol. 294:1999;443-456.
40. Yang Q., Osinska H., Klevitsky R., Robbins J. Phenotypic deficits in mice expressing a MyBP-C lacking the titin and myosin binding domains. J Mol Cell Cardiol. 33:2001;1649-1658.
41. McKenna W.J., Spirito P., Desnos M., Dubourg O., Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 77:1997;130-132.
42. Richard P., Isnard R., Carrier L., Dubourg O., Donatien Y., Mathieu B., et al. Double heterozygosity for mutations in the β-myosin heavy chain and in the cardiac myosin binding protein-C genes in a family with hypertrophic cardiomyopathy. J Med Genet. 36:1999;542-545.